Close Menu

NEW YORK – A 15-minute diagnostic test from Becton Dickinson to detect antigens of the SARS-CoV-2 virus has received Emergency Use Authorization by the US Food and Drug Administration.

The test, called the BD Veritor Plus SARS-CoV-2 assay, operates on the portable BD Veritor Plus Analyzer Instrument. It is authorized for high, moderate, and waived settings, which means that it can be used in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation, FDA noted in a statement issued on Monday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.